A Phase 1 Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder in Chronic Smokers and People With Mild or Moderate Asthma Compared to Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Zolmitriptan (Primary)
- Indications Migraine
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Acorda Therapeutics
- 27 Jan 2017 Status changed from active, no longer recruiting to completed.
- 21 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 29 Sep 2016 New trial record